New insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studies.

Celeste De Monte, Simone Carradori, Paola Chimenti, Daniela Secci, Luisa Mannina, Francesca Alcaro, Anél Petzer, Clarina I N'Da, Maria Concetta Gidaro, Giosuè Costa, Stefano Alcaro, Jacobus P Petzer

Index: Eur. J. Med. Chem. 82 , 164-71, (2014)

Full Text: HTML

Abstract

Although there are clinical trials and in vivo studies in literature regarding the anxiolytic and antidepressant activities of the components of Crocus sativus L., their effects on the human monoamine oxidases (hMAO-A and hMAO-B), enzymes which are involved in mental disorders and neurodegenerative diseases, have not yet been investigated. We have thus examined the hMAO inhibitory activities of crocin and safranal (the most important active principles in saffron) and, subsequently, designed a series of safranal derivatives to evaluate which chemical modifications confer enhanced inhibition of the hMAO isoforms. Docking simulations were performed in order to identify key molecular recognitions of these inhibitors with both isoforms of hMAO. In this regard, different mechanisms of action were revealed. This study concludes that safranal and crocin represent useful leads for the discovery of novel hMAO inhibitors for the clinical management of psychiatric and neurodegenerative disorders.Copyright © 2014 Elsevier Masson SAS. All rights reserved.